MiMedx to Acquire Stability Biologics for $10M at Closing in Cash, Stock

MiMedx Group, Inc. MDXG announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of  human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry. The Company also announced today its revised outlook for 2016, which includes the expected impact of the acquisition on forecasted 2016 results. Stability Biologics is privately held and was founded in 2010.  The company is headquartered in Nashville, Tennessee and its state-of-the-art tissue processing center is located in San Antonio, Texas.  During its five year history, Stability Biologics has evolved from its initial focus as a distributor of allografts, to its current position as an integrated provider in the surgical, spine and orthopedics sector of healthcare specializing in human tissue and bone product See full press release